Skip to content

Human Genetics: Pedigrees, LOD Scores, Karyotypes and Disorders

Pedigree analysis and risk calculation, LOD scores, karyotypes and ISCN notation, and chromosomal, single-gene and repeat-expansion disorders for CSIR NET.

  • 19 min read
  • Updated
On this page · 14 sections
  1. Prerequisites
  2. The Hook: Mapping a Gene Without a Single Planned Cross
  3. Pedigree Analysis
  4. Risk Calculation
  5. Linkage in Humans: The LOD Score
  6. Karyotypes
  7. Genetic Disorders
  8. Memory Tricks
  9. Don’t Confuse
  10. Common Mistakes
  11. Practice
  12. Quick Revision Table
  13. Key Takeaways
  14. What’s Next

Prerequisites

The Hook: Mapping a Gene Without a Single Planned Cross


Pedigree Analysis

Standard symbols

SymbolMeaning
Square / circle / diamondMale / female / sex unspecified
Filled symbolAffected
Half-filled (or dot in centre)Heterozygous carrier (autosomal) / carrier female (X-linked, dot)
Diagonal line through symbolDeceased
Horizontal line between two symbolsMating; double line = consanguineous mating
ArrowProband (propositus), the person through whom the family came to attention
Roman numerals / Arabic numeralsGenerations / individuals within a generation

Recognising the mode of inheritance

ModeKey featuresExamples
Autosomal dominant (AD)Affected in every generation (vertical); affected person usually has an affected parent; male-to-male transmission occurs; ~½ of children of an affected heterozygote affected; both sexes equallyHuntington disease, achondroplasia, Marfan syndrome, neurofibromatosis type 1, familial hypercholesterolaemia
Autosomal recessive (AR)Often skips generations (horizontal: affected siblings, unaffected parents); parents are carriers; consanguinity raises the risk; ¼ of children of two carriers affected; both sexes equallyCystic fibrosis, sickle-cell anaemia, β-thalassaemia, phenylketonuria, Tay–Sachs disease, oculocutaneous albinism
X-linked recessive (XLR)Mostly males affected; transmitted through carrier females; no male-to-male transmission; all daughters of an affected male are carriers; affected males related through females (“knight’s move”)Haemophilia A and B, Duchenne and Becker muscular dystrophy, red–green colour blindness, G6PD deficiency
X-linked dominant (XLD)Affected male passes it to all daughters and no sons; affected heterozygous female passes it to ½ of children of either sex; more affected females than males (often milder in females)X-linked hypophosphataemic rickets; Rett syndrome (MECP2, mostly sporadic in females)
Y-linkedOnly males, father to all sonsSRY; some Y-chromosome deletions causing azoospermia
MitochondrialTransmitted by females to all children; never by males; variable severity (heteroplasmy)LHON, MELAS, MERRF

A decision procedure

graph TD
    A["Affected child of two
unaffected parents?"] -->|"Yes"| B["Recessive
(or reduced penetrance / new mutation)"] A -->|"No, every affected person
has an affected parent"| C["Likely dominant"] B --> D{"Affected females,
or affected son of
affected father?"} D -->|"Yes"| E["Autosomal recessive"] D -->|"Only males, through
carrier mothers"| F["X-linked recessive
(probable)"] C --> G{"Male-to-male
transmission?"} G -->|"Yes"| H["Autosomal dominant
(rules out X-linked)"] G -->|"No; affected fathers have
all daughters affected,
no sons"| I["X-linked dominant"]

Rules that exclude a mode outright:

  • An affected daughter of an unaffected father excludes X-linked recessive (she would need his X).
  • Male-to-male transmission excludes any X-linked mode.
  • Two affected parents with an unaffected child exclude autosomal recessive (with full penetrance).
  • An affected father passing it to a child excludes mitochondrial inheritance.

Complications that make pedigrees ambiguous

ComplicationWhat it does
Reduced penetranceA dominant trait appears to skip a generation
Variable expressivityMildly affected relatives are missed
New (de novo) mutationAn isolated case with unaffected parents (common in achondroplasia; often linked to advanced paternal age)
Germline (gonadal) mosaicismTwo affected children from unaffected parents with a dominant disorder (e.g. osteogenesis imperfecta)
Locus heterogeneityMutations in different genes give the same phenotype; two deaf parents with recessive deafness can have all-hearing children if their mutations are in different genes (complementation)
Allelic heterogeneityMany different mutations in one gene (CFTR); affected people are often compound heterozygotes
PhenocopyAn environmentally caused copy of a genetic phenotype
AnticipationEarlier onset or greater severity in successive generations (repeat expansions)
ImprintingExpression depends on the parent of origin
Uniparental disomy (UPD)Both copies of a chromosome from one parent; can unmask a recessive allele or disrupt imprinting
Skewed X-inactivationA carrier female can be a manifesting heterozygote if most active Xs carry the mutant allele

Risk Calculation

Core probabilities

SituationProbability
Unaffected sibling of a person with an AR disorder (parents carriers)2/3 carrier (aa excluded; AA : Aa = 1 : 2)
Child of carrier × carrier¼ affected
Son of a carrier woman (XLR)½ affected
Daughter of an affected man (XLR)1 (obligate carrier)
Child of an affected heterozygote (AD, full penetrance)½
Random person from a population with carrier frequency 2pq2pq (from Hardy–Weinberg)

Worked example. A man whose sister has cystic fibrosis marries an unrelated woman from a population where the carrier frequency is 1/25. Risk that their first child has CF:

$$\tfrac{2}{3} \times \tfrac{1}{25} \times \tfrac{1}{4} = \tfrac{1}{150}$$

Bayesian (conditional) risk

Prior probabilities are revised by conditional information (unaffected children, a normal test result, age without symptoms).

StepCarrierNon-carrier
PriorP1 − P
Conditional (probability of the observed data given the status)L₁L₂
JointP × L₁(1 − P) × L₂
Posteriorjoint / sum of jointsjoint / sum of joints

Example (XLR). A woman’s mother is a known carrier of Duchenne muscular dystrophy. The woman has three unaffected sons.

  • Prior: carrier ½, non-carrier ½.
  • Conditional: if a carrier, P(three unaffected sons) = (½)³ = 1/8; if not, 1.
  • Joint: 1/16 and 1/2.
  • Posterior carrier = (1/16) / (1/16 + 8/16) = 1/9.

Consanguinity

The coefficient of inbreeding (F) is the probability that two alleles at a locus in an individual are identical by descent.

ParentsF of their child
First cousins1/16
Uncle–niece (or half-sibs)1/8
Siblings (or parent–child)1/4
Second cousins1/64

Frequency of a recessive homozygote among children of an inbred mating:

$$P(aa) = q^2 (1 - F) + qF$$

For a rare allele (q = 0.01), first-cousin offspring have \(0.0001 \times \tfrac{15}{16} + 0.01 \times \tfrac{1}{16} \approx 7.2 \times 10^{-4}\), about seven times the risk for unrelated parents (\(10^{-4}\)). The rarer the allele, the larger the relative effect of consanguinity, which is why affected children with very rare recessive disorders often have related parents.


Linkage in Humans: The LOD Score

To map a disease gene, geneticists follow its co-segregation with a polymorphic marker through families. Because families are small, evidence is summarised by the LOD score (logarithm of the odds), introduced by Newton Morton:

$$Z(\theta) = \log_{10} \frac{L(\text{data} \mid \theta)}{L(\text{data} \mid \theta = 0.5)}$$

θ is the recombination fraction between marker and disease locus; θ = 0.5 means no linkage.

For phase-known, fully informative meioses with R recombinants out of n:

$$Z(\theta) = \log_{10} \frac{\theta^{R}(1-\theta)^{n-R}}{(0.5)^{n}}$$

Worked example

Ten informative meioses, one recombinant:

θ0.010.050.100.200.300.40
Z(θ)0.971.511.601.441.090.62

The maximum (the maximum-likelihood estimate of θ) is at θ̂ = R/n = 0.1, with Z = 1.60.

Interpretation

LODInterpretation
≥ 3Significant evidence for linkage (odds 1000 : 1 in favour)
≤ −2Linkage excluded at that θ (odds 100 : 1 against)
Between −2 and 3Inconclusive; study more families
  • LOD scores from independent families add (they are logarithms of independent likelihood ratios). Three families each giving Z = 1.60 at θ = 0.1 give 4.80: significant.
  • With no recombinants in n phase-known meioses, Z(0) = n log₁₀ 2 = 0.301n, so at least 10 such meioses are needed to reach 3.
  • Phase unknown (the parent’s marker–disease phase is not known): each phase is given probability ½, and Z is computed from the average likelihood, so the same data give a lower LOD.
  • A significant LOD at a small θ places the gene within a few cM of the marker; the gene is then found by positional cloning (fine mapping, candidate genes, sequencing). Cystic fibrosis (CFTR, chromosome 7) is the classic success.

Karyotypes

Making a karyotype

  1. Cells: usually peripheral blood lymphocytes, stimulated to divide with phytohaemagglutinin (PHA); also amniocytes, chorionic villi, bone marrow or fibroblasts.
  2. Metaphase arrest: colchicine or colcemid (spindle inhibitors).
  3. Hypotonic treatment (KCl) swells the cells and spreads the chromosomes; fixation in methanol : acetic acid (3 : 1); dropping onto slides.
  4. Banding and staining, photography or imaging, and arrangement by size, centromere position and banding pattern.

Banding techniques

TechniqueMethodWhat stains
G-bandingMild trypsin + GiemsaDark bands AT-rich, gene-poor, late-replicating; standard clinical method
Q-bandingQuinacrine (fluorescent)Similar to G bands; bright distal Yq
R-bandingHeat denaturation + GiemsaReverse of G-banding (GC-rich bands dark)
C-bandingAlkali/heat, then GiemsaConstitutive heterochromatin (centromeres, 1q, 9q, 16q, distal Yq)
NOR (silver) stainingSilver nitrateActive nucleolar organiser regions (short arms of acrocentrics)

The human karyotype

46 chromosomes: 22 pairs of autosomes and XX or XY. Classical groups (by size and centromere position):

GroupChromosomesDescription
A1–3Large; 1 and 3 metacentric, 2 submetacentric
B4–5Large submetacentric
C6–12 and XMedium submetacentric
D13–15Medium acrocentric (satellites)
E16–18Small; 16 metacentric, 17–18 submetacentric
F19–20Small metacentric
G21–22 and YSmall acrocentric (Y lacks satellites)

Acrocentric chromosomes 13, 14, 15, 21 and 22 carry the rRNA gene clusters (NORs) on their short arms and are the ones that form Robertsonian translocations.

ISCN notation

Bands are named chromosome – arm (p short, q long) – region – band – sub-band: 7q31.2 is chromosome 7, long arm, region 3, band 1, sub-band 2.

KaryotypeMeaning
46,XX / 46,XYNormal female / male
47,XY,+21Male with trisomy 21
45,XTurner syndrome
47,XXYKlinefelter syndrome
46,XY,del(5)(p15)Deletion of 5p15 (cri-du-chat)
46,XX,t(9;22)(q34;q11)Reciprocal translocation (Philadelphia)
45,XY,der(14;21)(q10;q10)Balanced Robertsonian carrier
46,XX,inv(9)(p12q13)Pericentric inversion of 9
mos 45,X/46,XXMosaic
46,X,i(Xq)Isochromosome of Xq

Molecular cytogenetics

MethodDetectsLimitation
FISHSpecific sequences with fluorescent probes; microdeletions, translocations, interphase aneuploidy countsOnly what the probe targets
Spectral karyotyping / M-FISHEach chromosome painted a different colour; complex rearrangementsLow resolution for small changes
Array CGH / SNP arraysGenome-wide copy-number gains and losses (CNVs); SNP arrays also detect UPD and loss of heterozygosityCannot detect balanced translocations or inversions
Non-invasive prenatal testing (NIPT)Cell-free fetal DNA in maternal plasma, counted by sequencing; screens for common trisomiesA screening test; positives are confirmed by invasive testing

Invasive prenatal sampling uses chorionic villus sampling (earlier in pregnancy) or amniocentesis (later).


Genetic Disorders

Chromosomal disorders

DisorderKaryotypeNotes
Down syndrome47,+21 (most cases, free trisomy); also Robertsonian translocation and mosaic formsMost free trisomies arise from maternal meiosis I non-disjunction; risk rises with maternal age. Translocation cases can recur in families
Edwards syndrome47,+18Severe; clenched hands with overlapping fingers, rocker-bottom feet
Patau syndrome47,+13Severe; holoprosencephaly, cleft lip/palate, polydactyly
Turner syndrome45,X (also mosaics, i(Xq))Female, short stature, gonadal dysgenesis, webbed neck; the only viable human monosomy
Klinefelter syndrome47,XXYMale, tall, small testes, infertility, gynaecomastia; one Barr body
47,XYY—Usually tall males with normal fertility
Triple X47,XXXUsually mild; two Barr bodies
Cri-du-chat5p deletionCat-like cry in infancy
Williams syndrome7q11.23 microdeletion (includes elastin)Supravalvular aortic stenosis, characteristic personality
DiGeorge / velocardiofacial22q11.2 microdeletionThymic and parathyroid hypoplasia, heart defects
Prader–Willi / Angelman15q11–q13 (paternal / maternal loss)Imprinting disorders

Single-gene disorders

DisorderGene / productModeKey point
Cystic fibrosisCFTR (chloride channel), chromosome 7ARCommonest mutation ΔF508 (deletion of Phe508): misfolding, ER retention
Sickle-cell anaemiaHBB, Glu6ValARHbS polymerises when deoxygenated; carrier advantage against falciparum malaria
β-ThalassaemiaHBB (many mutations, often splicing or promoter)ARReduced or absent β chains
PhenylketonuriaPAH (phenylalanine hydroxylase)ARTreatable by low-phenylalanine diet; newborn screening
Tay–Sachs diseaseHEXA (hexosaminidase A)ARGM2 ganglioside accumulates in neurons
Albinism (oculocutaneous type 1)TYR (tyrosinase)ARNo melanin
Huntington diseaseHTT, CAG repeat in coding region (polyglutamine)ADLate onset; anticipation, greater with paternal transmission
AchondroplasiaFGFR3, gain of functionADMostly new mutations, associated with paternal age; homozygotes severely affected
Marfan syndromeFBN1 (fibrillin-1)ADPleiotropic connective-tissue disorder
Familial hypercholesterolaemiaLDLRAD (semi-dominant)Homozygotes far more severe
Neurofibromatosis type 1NF1 (neurofibromin, a Ras-GAP)ADVariable expressivity
Haemophilia A / BF8 / F9XLRClotting factor VIII / IX deficiency
Duchenne / Becker muscular dystrophyDMD (dystrophin)XLRDuchenne: usually frameshift deletions, no dystrophin; Becker: in-frame deletions, partly functional protein
G6PD deficiencyG6PDXLRHaemolysis after oxidant drugs or fava beans
Fragile X syndromeFMR1, CGG repeat in 5′ UTRX-linkedFull expansion → promoter methylation, silencing

Repeat-expansion disorders and anticipation

DisorderRepeatLocationInheritanceExpansion bias
Fragile X syndromeCGG5′ UTR of FMR1X-linkedExpansion to full mutation through mothers
Huntington diseaseCAGCoding (polyQ)ADLarger expansions through fathers
Myotonic dystrophy type 1CTG3′ UTR of DMPKADSevere congenital form through mothers
Friedreich ataxiaGAAIntron 1 of FXNARReduced frataxin
Spinocerebellar ataxias (several)CAGCodingADPolyglutamine

Fragile X shows the Sherman paradox: the risk of being affected depends on the position in the pedigree, because a premutation (an intermediate repeat length, without the syndrome) can expand to a full mutation when passed through a female. Normal males can carry a premutation (“normal transmitting males”) and pass it to all their daughters without expansion to a full mutation.


Memory Tricks

Don’t Confuse

ThisvsThat
X-linked recessive: affected father → all daughters carriers, no affected sonsvsX-linked dominant: affected father → all daughters affected, no sons
Mitochondrial: mother → all childrenvsXLR: carrier mother → half her sons
Locus heterogeneity (different genes)vsAllelic heterogeneity (different alleles of one gene)
Linkage (co-segregation in families)vsAssociation (allele frequency in cases vs controls)
LOD ≥ 3 (linkage)vsLOD ≤ −2 (exclusion)
G-banding (dark = AT-rich)vsR-banding (reverse)
Array CGH (copy number)vsKaryotype/FISH (also balanced rearrangements)
Duchenne (frameshift; no dystrophin)vsBecker (in-frame; reduced dystrophin)
Klinefelter 47,XXY malevsTurner 45,X female
Premutation (no syndrome, unstable)vsFull mutation (silenced FMR1)

Common Mistakes


Practice

All questions below are original practice questions written in CSIR NET style. They are not previous-year questions.

Level 1: Foundation

  1. What karyotype notation describes a male with Klinefelter syndrome?
  2. Which observation in a pedigree rules out X-linked inheritance?
  3. What LOD score is conventionally taken as significant evidence for linkage?
Answers
  1. 47,XXY.
  2. Male-to-male transmission (a father gives his son a Y, not an X).
  3. 3 (odds of 1000 : 1).

Level 2: Part B Style

Q1 (practice). In a pedigree, a rare trait appears in three generations. Every affected man has all daughters affected and all sons unaffected; affected women have affected sons and daughters in roughly equal numbers. The most likely mode is:

  • (a) Autosomal dominant
  • (b) X-linked recessive
  • (c) X-linked dominant
  • (d) Mitochondrial
Answer and explanation

(c). An affected father transmits his X to every daughter and never to a son. Mitochondrial inheritance would give no transmission at all from affected men; autosomal dominant would give affected sons from affected fathers.

Q2 (practice). Which karyotyping method would fail to detect a balanced reciprocal translocation?

  • (a) G-banded karyotype
  • (b) Spectral karyotyping
  • (c) Array comparative genomic hybridisation
  • (d) FISH with probes spanning the breakpoints
Answer and explanation

(c). Array CGH measures copy number; a balanced translocation has no net gain or loss.

Q3 (practice). Two first cousins marry. Their common grandfather was a known heterozygous carrier of a rare autosomal recessive allele; assume no other source of the allele in the family. The probability that their first child is affected is:

  • (a) 1/16
  • (b) 1/64
  • (c) 1/256
  • (d) 1/4
Answer and explanation

(b) 1/64. Each cousin is two transmissions from the grandfather (grandfather → parent ½, parent → cousin ½), so each is a carrier with probability 1/4. Child affected = 1/4 × 1/4 × 1/4 (both carriers, then aa) = 1/64. The trap (a) is the coefficient of inbreeding F = 1/16, which is the probability that the child is homozygous by descent for some grandparental allele, not for this specific allele (only one of the four grandparental alleles is the mutant one: 1/16 × 1/4 = 1/64 again).

Q4 (practice). A child with trisomy 21 has, at a marker tightly linked to the chromosome 21 centromere, two identical maternal alleles and one paternal allele. The mother is heterozygous at that marker. The error most likely occurred in:

  • (a) maternal meiosis I
  • (b) maternal meiosis II
  • (c) paternal meiosis I
  • (d) a post-zygotic mitosis in the father’s chromosome
Answer and explanation

(b). Two identical copies of one maternal centromeric allele means sister chromatids failed to separate: maternal meiosis II. A meiosis I error would give both of the mother’s different alleles.

Level 3: Part C Style

Q1 (practice). Three unrelated families segregating an autosomal dominant disease are typed for a marker. In each family there are 10 phase-known, fully informative meioses with exactly one recombinant.

(i) Calculate Z(θ) for one family at θ = 0.1 and θ = 0.2. (ii) What is the combined LOD at θ = 0.1, and what do you conclude? (iii) What is the minimum number of phase-known meioses with no recombinants needed to reach LOD 3 in a single family?

Answer and worked solution

(i) \(Z(0.1) = \log_{10}\dfrac{0.1 \times 0.9^{9}}{0.5^{10}} = \log_{10}\dfrac{0.03874}{9.766\times10^{-4}} = \log_{10} 39.67 = 1.60\). \(Z(0.2) = \log_{10}\dfrac{0.2 \times 0.8^{9}}{0.5^{10}} = \log_{10} 27.49 = 1.44\).

(ii) LODs add: 3 × 1.598 = 4.80 at θ = 0.1 (the maximum, since θ̂ = 3/30 = 0.1). This exceeds 3: significant linkage, with the gene about 10 cM from the marker.

(iii) \(Z(0) = n \log_{10} 2 = 0.301n \ge 3\) → n ≥ 9.97 → 10 meioses.

Q2 (practice). A woman’s mother is a proven carrier of haemophilia A. The woman herself has three unaffected sons. Which statements are correct?

(P) Before considering her sons, her probability of being a carrier is 1/2. (Q) After considering her three unaffected sons, her probability of being a carrier is 1/9. (R) The probability that her next son will be affected is 1/18. (S) Her daughters cannot be carriers, because her sons are unaffected.

  • (a) P, Q and R
  • (b) P and Q only
  • (c) Q and S only
  • (d) P, Q, R and S
Answer and worked solution

(a) P, Q and R.

CarrierNot a carrier
Prior1/21/2
P(3 unaffected sons)(1/2)³ = 1/81
Joint1/168/16
Posterior1/98/9

(R) P(next son affected) = 1/9 × 1/2 = 1/18. (S) is wrong: unaffected sons lower her probability of being a carrier but do not make it zero; daughters could still inherit a mutant X.

Q3 (practice). A man has a sister with cystic fibrosis; neither parent is affected. He marries an unrelated woman from a population in which CF affects 1 in 2,500 births. Calculate the risk that their first child has CF.

Answer and worked solution
  • Man: unaffected sibling of an affected person → carrier probability 2/3.
  • Woman: q² = 1/2500 → q = 0.02, p = 0.98, carrier frequency 2pq = 0.0392 ≈ 1/25.
  • Risk = 2/3 × 1/25 × 1/4 = 1/150 (≈ 0.0067). Using the exact 0.0392 gives 0.0065.

If they then have an affected child, both are proven carriers and the risk for each later child rises to 1/4: data from children update the parents’ genotypes.


Quick Revision Table

ItemFact
ADEvery generation; male-to-male; ½ risk; Huntington, achondroplasia, Marfan, NF1, FH
ARSkips; consanguinity; ¼ risk; unaffected sib 2/3 carrier; CF, sickle cell, PKU, Tay–Sachs
XLRMales; carrier mothers; no male-to-male; haemophilia, DMD, colour blindness, G6PD
XLDAffected father → all daughters; hypophosphataemic rickets, Rett
Y-linked / mitoFather → all sons / mother → all children
ExclusionsAffected daughter of unaffected father ≠ XLR; male-to-male ≠ X-linked; affected parents with unaffected child ≠ AR
BayesPrior × conditional → joint → normalise
FFirst cousins 1/16; P(aa) = q²(1 − F) + qF
LOD\(\log_{10}[L(\theta)/L(0.5)]\); ≥ 3 linkage, ≤ −2 exclusion; families add; 0 recombinants → 0.301n
Karyotype prepPHA, colchicine, hypotonic KCl, methanol : acetic acid 3 : 1
BandingG (Giemsa, trypsin), Q (quinacrine), R (reverse), C (heterochromatin), NOR (silver)
Acrocentrics13, 14, 15, 21, 22 (+ Y)
ISCN47,XY,+21; 45,X; del(5)(p15); t(9;22)(q34;q11); der(14;21)(q10;q10)
Array CGHCopy number only; misses balanced rearrangements
Chromosomal syndromesDown +21, Edwards +18, Patau +13, Turner 45,X, Klinefelter 47,XXY
Microdeletions5p (cri-du-chat), 7q11.23 (Williams), 22q11.2 (DiGeorge), 15q11–q13 (PWS/AS)
RepeatsCGG fragile X (5′ UTR), CAG Huntington (coding), CTG DM1 (3′ UTR), GAA Friedreich (intron, AR)
Anticipation biasHD paternal; fragile X and congenital DM1 maternal

Key Takeaways

What’s Next

Advertisement
Advertisement